Form 8-K NovaBay Pharmaceuticals, For: Nov 18

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/28/2026

1. ENPH
2. HOOD
3. NXPI
4. BA
5. STX
6. V
7. CSGP
8. LSTR
9. UPS
10. KIDS

Go back to Form 8-K NovaBay Pharmaceuticals, For: Nov 18

NovaBay Pharma (NBY) Reports In-Line Q3 EPS; Announces Corp. Restructuring, Names New CEO

November 19, 2015 6:59 AM EST

NovaBay Pharma (NYSE: NBY) reported Q3 EPS of ($0.07), in-line with the analyst estimate of ($0.07). Revenue for the quarter came in at $1.2 million versus the consensus estimate of $1.06 million.

NovaBay also announced a corporate restructuring to focus on the commercialization of its prescription Avenova® Lid and Lash Cleanser. NovaBay is also taking steps to reduce operating expenses with the goal of achieving positive cash flow from operations by the end of 2016. NovaBay Chairman Mark M. Sieczkarek has assumed the position of interim President and Chief Executive Officer, effective immediately, replacing former President... More